ADHD Med May Reduce Apathy in Alzheimer's Disease

Methylphenidate is associated with a significantly greater reduction in apathy in patients with Alzheimer's disease compared with placebo -- and has a good safety profile, a new phase 3 trial suggests.

Related Keywords

United States ,Canada ,Jeffreyl Cummings ,Las Vegas ,Jacobo Mintzer ,University Of South Carolina ,University Of Nevada ,Drug Administration ,National Institute On ,Neuropsychiatric Inventory ,Medical University ,South Carolina ,Dementia Methylphenidate ,Mini Mental State Examination ,Hopkins Verbal Learning Test ,Wechsler Adult Intelligence Scale ,Revised Digit ,Medscape Medical News ,National Institute ,Praxis Bioresearch ,Cerevel Therapeutics ,Alzheimers Disease ,Lzheimer Disease ,Dementia ,Neuropharmacology ,Adhd ,Attention Deficit Hyperactivity Disorder ,Ttention Deficit Hyperactivity Disorder Adhd ,Clinical Research ,Clinical Trials ,Linical Studies ,Mini Mental Status Exam ,Mse Mini Mental Status Exam ,Brain ,Caregiver ,Cognition ,Cognitive Testing ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,